Track topics on Twitter Track topics that are important to you
Praliciguat is an investigational, orally administered soluble guanylate cyclase (sGC) stimulator currently in Phase II clinical trials. Ironwood chief development officer and global development senior vice president Christopher
The post Ironwood secures FDA fast track designation for heart drug praliciguat appeared first on Pharma Business review.
Original Article: Ironwood secures FDA fast track designation for heart drug praliciguatNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...